Aussies first to try GLP-1 implant

Posted 25 July 2024 AM

Australians will be the first to try a GLP-1 implant to treat obesity, with US-based Vivani planning a clinical study in this country in the fourth quarter of this year.

Vivani is seeking regulatory clearance for the clinical study of NPM-115, an investigational six-month GLP-1 implant for chronic weight management in patients who are either obese or overweight with a related comorbidity. It hopes the implants will address two main challenges in GLP-1 therapy, namely medication non-adherence and tolerability.

To see the whole article, please login